ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Lupin and Mylan launch Nepexto, biosimilar etanercept in German market
August 27, 2020Etanercept was first approved for the treatment of rheumatoid arthritis in Germany in 2000 and since then has offered an effective treatment option for several chronic inflammatory diseases. -
Lupin and Mylan receive European Marketing Authorization for Nepexto, Biosimilar Etanercept
June 05, 2020A a phase 3 clinical study in patients with moderate-to-severe active rheumatoid arthritis confirmed equivalence of Nepexto to Enbrel in terms of efficacy, safety and immunogenicity. -
Mylan, Lupin Announce Positive CHMP Opinion for Biosimilar Nepexto
April 01, 2020Mylan and Lupin announced the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Nepexto® ...
Pharma Sources Insight January 2025
